Medicare Enrolled

Dr. George Dy, M.D.

Nephrology · Mansfield, PA
Practice pattern: Remote Monitoring — Significant remote device monitoring activity
Speaking/Promotional
40 W WELLSBORO ST, Mansfield, PA 16933
5706622002
In practice since 2006 (19 years)
NPI: 1962415067 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dy

Dr. George Dy is a nephrology specialist in Mansfield, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dy performed 595 Medicare services across 274 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dy received a total of $49,416 from 56 pharmaceutical and/or device companies across 843 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 595 Medicare services $49,416 industry payments

Medicare Practice Summary

Medicare Utilization ↗
595
Medicare services
Bottom 38% in PA for nephrology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
274
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~31 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
142 $226 $518
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
140 $91 $255
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
93 $10 $62
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
66 $3 $14
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
61 $61 $166
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
40 $88 $265
Routine 12-lead electrocardiogram (ECG)
A test that records the electrical activity of the heart using at least 12 leads to produce a tracing.
23 $4 $55
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
15 $3 $14
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
15 $153 $839
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$49,416
Total received (2018-2024)
Avg $7,059/year across 7 years
Top 4% in PA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
843
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$38,215 (77.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,633 (21.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$567 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,719
2023
$3,167
2022
$7,942
2021
$6,131
2020
$1,984
2019
$19,881
2018
$8,593

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$224
AstraZeneca Pharmaceuticals LP
$210
Novo Nordisk Inc
$190
Novartis Pharmaceuticals Corporation
$140
GlaxoSmithKline, LLC.
$131
Bayer Healthcare Pharmaceuticals Inc.
$107
ANI Pharmaceuticals, Inc.
$107
Ardelyx, Inc.
$100
Merck Sharp & Dohme LLC
$94
Abbott Laboratories
$58
PFIZER INC.
$54
Janssen Pharmaceuticals, Inc
$52
Xeris Pharmaceuticals, Inc.
$39
Lilly USA, LLC
$36
Phathom Pharmaceuticals, Inc.
$35
Otsuka America Pharmaceutical, Inc.
$22
Lundbeck LLC
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Alexion Pharmaceuticals, Inc.
$18
E.R. Squibb & Sons, L.L.C.
$18
Dexcom, Inc.
$16
SCPHARMACEUTICALS INC.
$14
ABBVIE INC.
$13
Top 3 companies account for 36.3% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$26,778
AstraZeneca Pharmaceuticals LP
$12,704
Amgen Inc.
$1,759
GlaxoSmithKline, LLC.
$1,000
Lilly USA, LLC
$885
Novo Nordisk Inc
$821
PFIZER INC.
$621
Boehringer Ingelheim Pharmaceuticals, Inc.
$514
Novartis Pharmaceuticals Corporation
$419
E.R. Squibb & Sons, L.L.C.
$314
Bayer Healthcare Pharmaceuticals Inc.
$237
Kowa Pharmaceuticals America, Inc.
$230
Astellas Pharma US Inc
$229
Merck Sharp & Dohme LLC
$221
SANOFI-AVENTIS U.S. LLC
$218
Mallinckrodt Enterprises LLC
$196
Dexcom, Inc.
$191
Merck Sharp & Dohme Corporation
$156
AbbVie Inc.
$137
Amarin Pharma Inc.
$136
Abbott Laboratories
$131
Ardelyx, Inc.
$126
Takeda Pharmaceuticals U.S.A., Inc.
$119
ANI Pharmaceuticals, Inc.
$107
DEXCOM, INC.
$87
ABBVIE INC.
$86
GENZYME CORPORATION
$85
Allergan Inc.
$77
Otsuka America Pharmaceutical, Inc.
$75
Biohaven Pharmaceuticals, Inc.
$72
Aurinia Pharma U.S., Inc.
$57
Radius Health, Inc.
$57
Horizon Therapeutics plc
$53
Xeris Pharmaceuticals, Inc.
$52
Biohaven Pharmaceutical Holding Company Ltd.
$47
Bayer HealthCare Pharmaceuticals Inc.
$38
Alexion Pharmaceuticals, Inc.
$36
Phathom Pharmaceuticals, Inc.
$35
AKEBIA THERAPEUTICS INC
$31
Regeneron Healthcare Solutions, Inc.
$26
Purdue Pharma L.P.
$26
Philips Electronics North America Corporation
$26
Lundbeck LLC
$21
CMP Pharma, Inc.
$20
ITI, Inc.
$20
Pulmonx Corporation
$19
CALLIDITAS THERAPEUTICS US INC.
$16
SCPHARMACEUTICALS INC.
$14
Circassia Pharmaceuticals Inc
$13
Keryx Biopharmaceuticals, Inc.
$13
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
Grifols USA, LLC
$13
Daiichi Sankyo Inc.
$13
Medicure Pharma Inc.
$12
Allergan, Inc.
$11
Sumitomo Pharma America, Inc.
$1
Top 3 companies account for 83.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · ADVAIR · AIRSUPRA · ANORO · ANORO ELLIPTA · AURYXIA · Aimovig · Amitiza · Auryxia · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYSTOLIC · CAMZYOS · CAPLYTA · CHANTIX · CHARTIS CATHETER · CaroSpir · Corlanor · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE 3 · FUROSCIX · Fabhalta · FreeStyle Libre 2 · GEMTESA · GVOKE HYPOPEN · GVOKE PFS · IBSRELA · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LINZESS · LOKELMA · LUPKYNIS · LYRICA · Livalo · MOUNJARO · MOVANTIK · MYRBETRIQ · Myrbetriq · NURTEC ODT · OFIRMEV · Otezla · Ozempic · PAXLOVID · PRADAXA · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PURIFIED CORTROPHIN GEL · Parsabiv · Prolastin-C Liquid · Prolia · QULIPTA · REXULTI · REYVOW · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · TARPEYO · TAVNEOS · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · Tymlos · UBRELVY · ULTOMIRIS · Uloric · VERQUVO · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Victoza · Wegovy · XARELTO · XIFAXANIBSD · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (77%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for nephrology in PA.

Looking for a nephrology specialist in Mansfield?
Compare nephrologists in the Mansfield area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
6
Per 100K population
14.6
County median income
$62,932
Nearest hospital
TROY COMMUNITY HOSPITAL
13.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dy is a remote monitoring specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 4% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dy experienced with dialysis services for adults, 2-3 visits per month?
Based on Medicare claims data, Dr. Dy performed 142 dialysis services for adults, 2-3 visits per month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dy receive payments from pharmaceutical companies?
Yes. Dr. Dy received a total of $49,416 from 56 companies across 843 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dy's costs compare to other nephrologists in Mansfield?
Dr. Dy's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →